GGrantIndex
← Leaderboards

Sheryl F. Kelsey

University Of Pittsburgh At Pittsburgh

$8,354,235
Attributed
$8,354,235
Total exposure
4
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $9.1M · FY200511
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11

Funding mix

By agency

NIH$30,419,806 · 5

By mechanism

U01$28,981,732 · 3
P50$1,300,934 · 1
R03$137,140 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Pittsburgh At Pittsburgh

Same institution · by research overlap

Others in their field

Top investigators on “Evaluation

Research focus

EvaluationFollow-UpCoronaryMyocardial InfarctionMortality Vital StatisticsReportingDatabasesEventManuscriptsInterviewData ManagementIschemiaSafetyTranslatingMyocardial Ischemia /HypoxiaMedicalCoronary ArteriosclerosisGene ExpressionClinical Research SiteDesignCardiovascular Disorder DiagnosisDiagnosis Design /EvaluationHormone Regulation /Control MechanismHuman Data

Grant awards (21)

Dynamic Evaluation of Coronary Intervention Renewal: Drug-Eluting Stents$742,170
U01 · FY2011 · HL · contact PI
Dynamic Evaluation of Coronary Intervention Renewal: Drug-Eluting Stents$732,168
U01 · FY2010 · HL · contact PI
BARI II: A TRIAL OF REVASC. & GLYCEMIC CONTROL IN NIDDM$1,129,551
U01 · FY2009 · HL · contact PI
Dynamic Evaluation of Coronary Intervention Renewal: Drug-Eluting Stents$753,041
U01 · FY2009 · HL · contact PI
Cardiovascular Events in Women's Ischemia Syndrome Evaluation$61,783
R03 · FY2009 · AG · contact PI
BARI II: A TRIAL OF REVASC. & GLYCEMIC CONTROL IN NIDDM$1,740,456
U01 · FY2008 · HL · contact PI
Dynamic Evaluation of Coronary Intervention Renewal: Drug-Eluting Stents$748,083
U01 · FY2008 · HL · contact PI
Core--Biostatistics and Data Management$224,756
P50 · FY2008 · HL · contact PI
Cardiovascular Events in Women's Ischemia Syndrome Evaluation$75,357
R03 · FY2008 · AG · contact PI
BARI II: A TRIAL OF REVASC. & GLYCEMIC CONTROL IN NIDDM$2,646,947
U01 · FY2007 · HL · contact PI
Core--Biostatistics and Data Management$232,179
P50 · FY2007 · HL · contact PI
BARI II: A TRIAL OF REVASC. & GLYCEMIC CONTROL IN NIDDM$8,776,719
U01 · FY2006 · HL · contact PI
Core C--Biostatistics and Data Management$283,438
P50 · FY2006 · HL · contact PI
BARI II: A TRIAL OF REVASC. &GLYCEMIC CONTROL IN NIDDM$7,771,898
U01 · FY2005 · HL
Women's Ischemia Syndrome Evaluation$630,764
U01 · FY2005 · HL
Core C--Biostatistics and Data Management$277,114
P50 · FY2005 · HL
Women's Ischemia Syndrome Evaluation$803,512
U01 · FY2004 · HL
Core C--Biostatistics and Data Management$283,447
P50 · FY2004 · HL
Women's Ischemia Syndrome Evaluation$810,057
U01 · FY2003 · HL
Women's Ischemia Syndrome Evaluation$842,543
U01 · FY2002 · HL
Women's Ischemia Syndrome Evaluation$853,823
U01 · FY2001 · HL